Augmented high dose cyclophosphamide, etoposide, and carmustine followed by transplantation with peripheral blood stem cells (PBSC) in the treatment of relapsed or refractory Hodgkin’s disease
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2006-02-01
Language
English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Elsevier
Abstract
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Schwartz, J. E., Robertson, M. J., Cornetta, K. G., Cripe, L. D., Nelson, R. P., Yiannoutsos, C. T., Baute, J. A., Wood, L. L., & Abonour, R. (2006). Augmented high dose cyclophosphamide, etoposide, and carmustine followed by transplantation with peripheral blood stem cells (PBSC) in the treatment of relapsed or refractory Hodgkin’s disease. Biology of Blood and Marrow Transplantation, 12(2), 97–98. https://doi.org/10.1016/j.bbmt.2005.11.298
ISSN
1083-8791
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Biology of Blood and Marrow Transplantation
Source
Publisher
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Final published version